Jeffery Shawn Zweizig
Examiner (ID: 11083, Phone: (571)272-1758 , Office: P/2842 )
Most Active Art Unit | 2816 |
Art Unit(s) | 2816, 2849, 2842, 2504 |
Total Applications | 2555 |
Issued Applications | 2334 |
Pending Applications | 90 |
Abandoned Applications | 130 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6856852
[patent_doc_number] => 20030130353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Methods of treating fibromyalgia'
[patent_app_type] => new
[patent_app_number] => 10/028547
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7361
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130353.pdf
[firstpage_image] =>[orig_patent_app_number] => 10028547
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/028547 | Methods of treating fibromyalgia | Dec 18, 2001 | Issued |
Array
(
[id] => 5788714
[patent_doc_number] => 20020161013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Method of local anesthesia and analgesia'
[patent_app_type] => new
[patent_app_number] => 10/006122
[patent_app_country] => US
[patent_app_date] => 2001-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4320
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20020161013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10006122
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/006122 | Method of local anesthesia and analgesia | Dec 9, 2001 | Abandoned |
Array
(
[id] => 6870691
[patent_doc_number] => 20030083381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Hair growth or hair formation controlling agents'
[patent_app_type] => new
[patent_app_number] => 09/980197
[patent_app_country] => US
[patent_app_date] => 2001-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12092
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083381.pdf
[firstpage_image] =>[orig_patent_app_number] => 09980197
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/980197 | Hair growth or hair formation controlling agents | Nov 29, 2001 | Abandoned |
09/958960 | Therapy with cannabinoids in the treatment of cerebral tumor | Nov 26, 2001 | Abandoned |
Array
(
[id] => 6552760
[patent_doc_number] => 20020111328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer'
[patent_app_type] => new
[patent_app_number] => 09/993896
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1195
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111328.pdf
[firstpage_image] =>[orig_patent_app_number] => 09993896
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/993896 | Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer | Nov 26, 2001 | Abandoned |
Array
(
[id] => 1369776
[patent_doc_number] => 06566389
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Therapeutic uses of melatonin'
[patent_app_type] => B1
[patent_app_number] => 09/979583
[patent_app_country] => US
[patent_app_date] => 2001-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1779
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566389.pdf
[firstpage_image] =>[orig_patent_app_number] => 09979583
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/979583 | Therapeutic uses of melatonin | Nov 25, 2001 | Issued |
Array
(
[id] => 6241513
[patent_doc_number] => 20020044978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Method of manufacture of garlic extract for use as a preventive and therapeutic agent for human prostate and bladder cancers'
[patent_app_type] => new
[patent_app_number] => 09/971667
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3377
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20020044978.pdf
[firstpage_image] =>[orig_patent_app_number] => 09971667
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/971667 | Method of manufacture of garlic extract for use as a preventive and therapeutic agent for human prostate and bladder cancers | Nov 15, 2001 | Abandoned |
Array
(
[id] => 5923381
[patent_doc_number] => 20020115694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Methods for the treatment and prevention of urinary stone disease'
[patent_app_type] => new
[patent_app_number] => 09/992973
[patent_app_country] => US
[patent_app_date] => 2001-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4179
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115694.pdf
[firstpage_image] =>[orig_patent_app_number] => 09992973
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/992973 | Methods for the treatment and prevention of urinary stone disease | Nov 13, 2001 | Issued |
Array
(
[id] => 6861675
[patent_doc_number] => 20030092683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Use of tetracyclines as neuro-protective agents and for the treatment of parkinson\'s disease and related disorders'
[patent_app_type] => new
[patent_app_number] => 10/007850
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1767
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092683.pdf
[firstpage_image] =>[orig_patent_app_number] => 10007850
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/007850 | Use of tetracyclines as neuro-protective agents and for the treatment of parkinson's disease and related disorders | Nov 12, 2001 | Abandoned |
Array
(
[id] => 6788237
[patent_doc_number] => 20030139476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'METHOD OF TREATING CHRONIC FATIGUE SYNDROME'
[patent_app_type] => new
[patent_app_number] => 10/014149
[patent_app_country] => US
[patent_app_date] => 2001-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7420
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20030139476.pdf
[firstpage_image] =>[orig_patent_app_number] => 10014149
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/014149 | Method of treating chronic fatigue syndrome | Nov 4, 2001 | Issued |
Array
(
[id] => 6082654
[patent_doc_number] => 20020082280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Method of inhibiting neoplastic cells with benzimidazole derivatives'
[patent_app_type] => new
[patent_app_number] => 10/012672
[patent_app_country] => US
[patent_app_date] => 2001-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59878
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082280.pdf
[firstpage_image] =>[orig_patent_app_number] => 10012672
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/012672 | Method of inhibiting neoplastic cells with benzimidazole derivatives | Nov 4, 2001 | Abandoned |
Array
(
[id] => 6766212
[patent_doc_number] => 20030100612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid'
[patent_app_type] => new
[patent_app_number] => 09/985246
[patent_app_country] => US
[patent_app_date] => 2001-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2327
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100612.pdf
[firstpage_image] =>[orig_patent_app_number] => 09985246
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/985246 | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid | Nov 1, 2001 | Issued |
Array
(
[id] => 1298433
[patent_doc_number] => 06627659
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-30
[patent_title] => 'Methods of decreasing the effects of oxidative stress using N-acetylcysteine'
[patent_app_type] => B1
[patent_app_number] => 09/926363
[patent_app_country] => US
[patent_app_date] => 2001-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 1473
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/627/06627659.pdf
[firstpage_image] =>[orig_patent_app_number] => 09926363
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/926363 | Methods of decreasing the effects of oxidative stress using N-acetylcysteine | Oct 21, 2001 | Issued |
Array
(
[id] => 1311761
[patent_doc_number] => 06613768
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'Treatment of female arousal disorder'
[patent_app_type] => B1
[patent_app_number] => 10/031321
[patent_app_country] => US
[patent_app_date] => 2001-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3823
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613768.pdf
[firstpage_image] =>[orig_patent_app_number] => 10031321
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/031321 | Treatment of female arousal disorder | Oct 18, 2001 | Issued |
Array
(
[id] => 5987617
[patent_doc_number] => 20020099079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Hydroxylansoprazole methods'
[patent_app_type] => new
[patent_app_number] => 10/046464
[patent_app_country] => US
[patent_app_date] => 2001-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3050
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20020099079.pdf
[firstpage_image] =>[orig_patent_app_number] => 10046464
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/046464 | Hydroxylansoprazole methods | Oct 18, 2001 | Abandoned |
09/869030 | Combination chemotherapy | Oct 17, 2001 | Abandoned |
Array
(
[id] => 1037585
[patent_doc_number] => 06872734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-29
[patent_title] => 'Use of tiagabine for treatment of diabetic neuropathy and migraine'
[patent_app_type] => utility
[patent_app_number] => 10/041782
[patent_app_country] => US
[patent_app_date] => 2001-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1478
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872734.pdf
[firstpage_image] =>[orig_patent_app_number] => 10041782
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/041782 | Use of tiagabine for treatment of diabetic neuropathy and migraine | Oct 17, 2001 | Issued |
Array
(
[id] => 1341389
[patent_doc_number] => 06589993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-08
[patent_title] => 'Treating vancomycin-intermediates and multiresistant staphylococci infection with thiamphenicol or a salt thereof'
[patent_app_type] => B2
[patent_app_number] => 09/958945
[patent_app_country] => US
[patent_app_date] => 2001-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1629
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/589/06589993.pdf
[firstpage_image] =>[orig_patent_app_number] => 09958945
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/958945 | Treating vancomycin-intermediates and multiresistant staphylococci infection with thiamphenicol or a salt thereof | Oct 15, 2001 | Issued |
Array
(
[id] => 5936614
[patent_doc_number] => 20020061854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by use of hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol'
[patent_app_type] => new
[patent_app_number] => 09/972850
[patent_app_country] => US
[patent_app_date] => 2001-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7619
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061854.pdf
[firstpage_image] =>[orig_patent_app_number] => 09972850
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/972850 | Food additive or product or a pharmaceutical preparation, comprising hydroxymatairesinol | Oct 9, 2001 | Issued |
Array
(
[id] => 1389375
[patent_doc_number] => 06548545
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-15
[patent_title] => 'Treatment of interstitial cystitis using topical application of menthol and L-arginine'
[patent_app_type] => B1
[patent_app_number] => 09/968055
[patent_app_country] => US
[patent_app_date] => 2001-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2330
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/548/06548545.pdf
[firstpage_image] =>[orig_patent_app_number] => 09968055
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/968055 | Treatment of interstitial cystitis using topical application of menthol and L-arginine | Sep 30, 2001 | Issued |